Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 - Liu, L; Cao, Y; Chen, C (Cancer Res, 2006)
et al.